Finance

Lists
NVLG:TLV
Novolog Pharm Up 1966 Ltd
ILA 76.90
+6.36%
(+4.60) 1D
Sep 17, 5:29:43 PM GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for NVLG...
Open
ILA 72.30
High
ILA 78.00
Low
ILA 72.30
Mkt. cap
392.86M
Avg. vol.
539.76K
Volume
1.20M
Dividend
6.36%
Quarterly dividend
ILA 1.22
Ex-dividend date
Dec 1, 2025
52-wk high
ILA 148.80
52-wk low
ILA 66.30
EPS
-ILA 0.00
Shares outstanding
510.87M
No. of employees
916
Open
ILA 72.30
High
ILA 78.00
Low
ILA 72.30
Mkt. cap
392.86M
Avg. vol.
539.76K
Volume
1.20M
Dividend
6.36%
Quarterly dividend
ILA 1.22
Ex-dividend date
Dec 1, 2025
52-wk high
ILA 148.80
52-wk low
ILA 66.30
EPS
-ILA 0.00
Shares outstanding
510.87M
No. of employees
916
About Novolog Pharm Up 1966 Ltd
CEOAviad Bussi
Employees916
Founded1966
Headquarters-
SectorHealth care provider
Websitenovolog.co.il
Previous reportsAll values in ILS
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in ILS
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
483.58M
373.25M
505.83M
451.87M
Cost of goods sold
447.35M
306.78M
474.69M
415.31M
Cost of revenue
447.35M
306.78M
474.69M
415.31M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.35M
31.08M
26.07M
25.08M
Operating expense
26.92M
29.91M
26.05M
27.64M
Total operating expenses
474.27M
336.70M
500.75M
442.95M
Operating income
9.31M
36.55M
5.08M
8.92M
Other non operating income
-
-
-
-270.00K
EBT including unusual items
6.42M
-6.85M
-608.00K
2.43M
EBT excluding unusual items
5.52M
29.77M
-608.00K
2.43M
Income tax expense
2.16M
-1.23M
-796.00K
1.89M
Effective tax rate
33.59%
17.99%
130.92%
77.75%
Other operating expenses
567.00K
-1.17M
-19.00K
2.56M
Net income
3.95M
-5.63M
442.00K
559.00K
Net profit margin
0.82%
-1.51%
0.09%
0.12%
Earnings per share
-
-
-
-
Interest and investment income
1.53M
902.00K
862.00K
2.96M
Interest expense
-5.68M
-3.57M
-6.69M
-9.06M
Net interest expenses
-4.15M
-2.67M
-5.82M
-6.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
19.91M
44.43M
14.94M
18.72M
Gain or loss from assets sale
-
-8.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps